Cargando…
Immune Profiling of Syngeneic Murine and Patient GBMs for Effective Translation of Immunotherapies
Immunotherapy for brain tumors remains elusive, unlike many other cancer types for which it is one of the most promising therapeutic options. Recent studies have comprehensively profiled the immune-landscape of the highly malignant brain tumor, glioblastoma (GBM) in patients and identified novel imm...
Autores principales: | Khalsa, Jasneet Kaur, Shah, Khalid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996275/ https://www.ncbi.nlm.nih.gov/pubmed/33668856 http://dx.doi.org/10.3390/cells10030491 |
Ejemplares similares
-
Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types
por: Khalsa, Jasneet Kaur, et al.
Publicado: (2020) -
Response of Syngeneic Murine Lymphomata to Immunotherapy in Relation to the Antigencity of the Tumour
por: Parr, Iris
Publicado: (1972) -
Predicting patterns of failure in temporal lobe GBMs: possible implications on radiotherapy treatment portals
por: Jayamanne, Dasantha, et al.
Publicado: (2018) -
TRIM22 orchestrates the proliferation of GBMs and the benefits of TMZ by coordinating the modification and degradation of RIG-I
por: Fei, Xiaowei, et al.
Publicado: (2022) -
Development of an orthotopic syngeneic murine model of colorectal cancer for use in translational research
por: Evans, Jonathan P, et al.
Publicado: (2019)